Copyright
©The Author(s) 2017.
World J Gastroenterol. Nov 7, 2017; 23(41): 7470-7477
Published online Nov 7, 2017. doi: 10.3748/wjg.v23.i41.7470
Published online Nov 7, 2017. doi: 10.3748/wjg.v23.i41.7470
Table 2 Comparison of portal vein thrombosis changes between the two groups
SMA group (n = 20) | TIPS group (n = 20) | ||||||
Time (mo) | 6 | 12 | 24 | 6 | 12 | 24 | P value |
Recanalization | 15 | 15 | 13 | 12 | 13 | 11 | 0.239 (6 mo) |
Improved | 4 | 4 | 4 | 4 | 2 | 3 | 0.307 (12 mo) |
Stable | 1 | 1 | 3 | 4 | 2 | 2 | 0.304 (24 mo) |
Worse | 0 | 0 | 0 | 0 | 3 | 4 |
- Citation: Jiang TT, Luo XP, Sun JM, Gao J. Clinical outcomes of transcatheter selective superior mesenteric artery urokinase infusion therapy vs transjugular intrahepatic portosystemic shunt in patients with cirrhosis and acute portal vein thrombosis. World J Gastroenterol 2017; 23(41): 7470-7477
- URL: https://www.wjgnet.com/1007-9327/full/v23/i41/7470.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i41.7470